跳至主要内容
临床试验/NCT01298544
NCT01298544已完成4 期

A Phase 4, Open-label Study to Evaluate Persistence of the Antibody Response Elicited by Prevenar in Healthy Children in China Who Have Been Previously Immunized With a 4-dose Series of a Pneumococcal Conjugate Vaccine During Infancy in Study 0887x-101518

Pfizer10 个研究点 分布在 1 个国家目标入组 335 人开始时间: 2010年11月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
Pfizer
入组人数
335
试验地点
10
主要终点
Geometric Mean Concentration (GMC) for Serotype-specific Pneumococcal Immunoglobulin G (IgG) Antibody, 36 Months After the Toddler Dose

研究概览

简要总结

In 2005, Wyeth conducted study 0887X-101518 (NCT00488826) in which Chinese infants received either Prevenar alone (Group 1), Prevenar given with a Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccine (Group 2) or DTaP alone (Group 3). This follow up study (at least 3 years after the last vaccination) will assess the antibody concentrations in children who previously completed Wyeth study 0887X-101518.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
4 Years 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects who participated in and completed Wyeth study 0887X
  • Healthy subject as determined by medical history, physical examination, and judgment of the investigator.

排除标准

  • Vaccination with any licensed or investigational pneumococcal vaccine since completion of Wyeth study 0887X
  • History of culture proven invasive disease caused by S pneumoniae since the completion of Wyeth study 0887X
  • Known or suspected immune deficiency or suppression since participation in Wyeth study 0887X 101518.

研究组 & 干预措施

All subjects

Other

干预措施: Blood draw (Procedure)

结局指标

主要结局

Geometric Mean Concentration (GMC) for Serotype-specific Pneumococcal Immunoglobulin G (IgG) Antibody, 36 Months After the Toddler Dose

时间窗: Day 1 (36 months after toddler dose)

Antibody geometric mean concentration (GMC) as measured by mcg/mL for 7 pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F). GMC (7vPnC, 7vPnC/DTaP, and DTap) and corresponding 2-sided 95% confidence intervals (CI) were evaluated. Geometric means (GMs) were calculated using all participants with available data for the specified blood draw.

次要结局

未报告次要终点

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验